ICAD

iCAD Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ICAD price

iCAD

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ICAD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ICAD

Valuation

P/E

0.00

Sector -0.16

Industry 2.77

P/BV

0.00

Sector 1.93

Industry 2.37

P/Revenue (PSR)

Sector 1.67

Industry 1.97

EV/EBITDA

20.86

Sector -55.30

Industry -73.25

EV/EBIT

17.73

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

Sector 0.91

Industry 1.07

P/Net Current Assets

0.00

Sector -24.70

Industry -5.25

P/Working Capital

0.00

Sector -5.32

Industry 3.11

EPS

-0.19

Sector -0.79

Industry -0.61

BVPS

1.14

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

85.56%

Sector 48.28%

Industry 50.49%

EBITDA Margin

-19.71%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

-23.20%

Sector -62.93%

Industry -21.31%

Operating Margin

-30.52%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-26.73%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.12

Sector 0.13

Industry 0.15

Profitability

ROE

-16.95%

Sector -31.93%

Industry -27.86%

ROA

-13.23%

Sector -28.25%

Industry -27.56%

ROIC

-27.54%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.66

Sector 1.85

Industry 1.98

Net Debt / EBITDA

20.86

Sector -42.46

Industry -72.45

Net Debt / EBIT

17.73

Sector -37.26

Industry -7.11

Net Debt / Equity

-0.65

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.00

Sector -0.72

Industry 0.10

Equity/Assets

0.78

Sector 0.43

Industry 0.45

Liabilities/Assets

0.22

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

-10.30%

Sector -

Industry -

5Y Earnings CAGR

-14.23%

Sector -

Industry -

Fundamentals ICAD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ICAD iCAD Inc.	$0.00	-	0.00%	0.00	0.00	-16.95%	-26.73%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.84	-2.34%	0.00%	11.50	1.42	12.32%	20.69%
DXCM DexCom Inc.	$90.49	18.47%	0.00%	34.80	13.27	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.23	11.53%	0.00%	51.94	4.86	9.36%	15.41%
BDX Becton Dickinson and Company	$189.33	-0.19%	2.21%	55.38	2.14	3.86%	6.30%
ALGN Align Technology Inc.	$157.75	11.11%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.75	20.18%	1.42%	49.15	11.14	22.66%	26.71%
SNN Smith & Nephew PLC	$28.91	-19.76%	2.63%	11.09	2.41	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ICAD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT iCAD

iCAD Inc.

Average Investor10 user rating

4.0 (0 people)

United States

42 years

Founded: 1984

1992

Time since IPO - 34 years

114

Employees

iCAD Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $30.79 million.

The company employs approximately 114 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, iCAD Inc. reported $19.53 million in revenue, generating net income of $-5.22 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ICAD.

Market cap

Net worth

$30.79 million

$30,790,000.00

Assets

$39.47 million

$39,470,000.00

Total Shares Outstanding

27.00 million

27,000,000

Average Daily Trading Volume

$323.87 Thousand

$323,873.40

Sector

Health

Industry

Medical Supplies and Equipment

ICAD

ICAD revenue and profits

Financial Results ICAD

DRAG THE FRAME TO SEE MORE DATA

ICAD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75